Who is sponsoring NCT05227495?

NCT05227495 is sponsored by Chang Gung Memorial Hospital.

What drugs are being tested in NCT05227495?

Interventions in NCT05227495: VR cognitive training, Traditional cognitive training.

What condition does NCT05227495 study?

NCT05227495 studies Community-dwelling Elderly, Virtual Reality.

Is NCT05227495 still recruiting?

NCT05227495 is currently status unknown. Last updated 25 February 2022.

Last reviewed 2022-02-25 · How we verify

NCT05227495

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of the Fully Immersive Leisure-based Virtual Reality Cognitive Training for Community-dwelling Elderly

Status unknown NA Last updated 25 February 2022

What this trial tests

NA trial testing VR cognitive training in Community-dwelling Elderly in 60 participants. Status unknown.

Timeline

1 April 2021

Primary endpoint
31 December 2022

31 December 2022

Quick facts

Lead sponsor	Chang Gung Memorial Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	60
Start date	1 April 2021
Primary completion	31 December 2022
Estimated completion	31 December 2022
Sites	1 location across Taiwan

Drugs / interventions tested

VR cognitive training
Traditional cognitive training

Conditions studied

Community-dwelling Elderly — all drugs for Community-dwelling Elderly →
Virtual Reality — all drugs for Virtual Reality →

Sponsor

Chang Gung Memorial Hospital

Who can join

60 and older, any sex, with Community-dwelling Elderly or Virtual Reality. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to (1) determine the feasibility and usability of immersive leisure-based VR cognitive training; (2) identify the intervention effects of immersive leisure-based VR cognitive training on cognitive function, daily function, and quality of life for elderly with community-dwelling elderly

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Exergaming for dementia and mild cognitive impairment.
Voinescu A, Papaioannou T, Petrini K, Stanton Fraser D. · · 2024 · cited 9× · PMID 39319863 · DOI 10.1002/14651858.cd013853.pub2
Effects of immersive leisure-based virtual reality cognitive training on cognitive and physical function in community-based older adults: A randomized controlled trial.
Chuang IC, Abdullahi A, Chen IC, Wu YR, et al · · 2025 · PMID 40171148 · DOI 10.1177/20552076251328491

Verify or expand the search:

Other trials of VR cognitive training

Trials testing the same drug.

NCT06236919 — E-Emotio Project A Gamified Preventive School-based Paradigm Using Virtual Reality Technologies for Improving Emotional · NA · recruiting
NCT05682469 — Effects and Mechanism of the Fully Immersive Virtual Reality Cognitive Training Based on Leisure Activities · NA · unknown

Other Chang Gung Memorial Hospital trials

Trials by the same sponsor.

NCT07419789 — Precision Care for Older Persons · NA · not yet recruiting
NCT07248345 — Virtual Reality Intervention for Family Caregivers of Persons Living With Dementia · NA · not yet recruiting
NCT07036978 — Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer · not yet recruiting
NCT07489833 — Metabolomic Pathways and Traditional Chinese Medicine Body Constitution in Cancer-related Fatigue · not yet recruiting
NCT07496528 — The ACURE Trial: Acupuncture for Colorectal Recovery · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05227495 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chang Gung Memorial Hospital
Last refreshed: 25 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05227495.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing